At meeting held on 25 May 2021
The Board of Sun Pharma Advanced Research Company at its meeting held on 25 May 2021 has approved the following:Resignation of Dilip Shanghvi as the Managing Director of the Company with immediate effect. He will continue to be associated with the Board in his capacity as a non executive director and Chairman of the company.
The Board has appointed Anil Raghavan, as a Chief Executive Officer (CEO) and whole time key managerial personnel of the Company with immediate effect, for a term of five years i.e upto 24 May 2026.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
